Filter posts

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

Sen Menendez Asks SEC to Investigate IPR Abuses

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate …

11 Days Until BIO 2015: IP Networking and Meetup Opportunities

This year’s BIO International Convention is fast approaching, with plenty of opportunities for the best …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

When The Deck is Stacked Against Innovators, Everyone Loses

Yesterday, I took part in a series of successful meetings on Capitol Hill regarding the …

Should the USPTO Allow the Patenting of Living Organisms?

Last year, a question was submitted to the GMO advocacy website GMOAnswers about whether or …

The Washington Post: Are Patents the Problem?

Tamar Haspel, food columnist for the Washington Post, looks at the issue of seed patents …

Detailed Report Examines the Crucial Role of Patents in Genetic Testing

In The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic …

Protecting your IP Overseas

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications …

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …